Kinetics of human serum butyrylcholinesterase and its inhibition by a novel experimental Alzheimer therapeutic, bisnorcymserine-Reference-Cited by-同舟云学术

Kinetics of human serum butyrylcholinesterase and its inhibition by a novel experimental Alzheimer therapeutic, bisnorcymserine

Published:2006-09-08 Issue:1 Volume:10 Page:43-51
ISSN:1875-8908
Container-title:Journal of Alzheimer's Disease
language:
Short-container-title:JAD

Author:

Kamal Mohammad A.¹,Klein Peter²,Yu Qian-sheng³,Tweedie David³,Li Yazhou³,Holloway Harold W.³,Greig Nigel H.³

Affiliation:

1. Enzymoics, 7 Peterlee Pl., Hebersham, NSW 2770, Australia

2. TAFE, Ultimo, NSW 2007, Australia

3. Drug Design & Development Section, Laboratory of Neurosciences, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224, USA

Publisher

IOS Press

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, synthesis, and multitargeted profiling of N-benzylpyrrolidine derivatives for the treatment of Alzheimer’s disease;Bioorganic & Medicinal Chemistry;2020-11

2. Synthesis, Docking Study and Biological Activities Evaluation of 1‐Amidoalkyl‐2‐naphthol Derivatives as Dual Inhibitors of Cholinesterase and α‐Glucosidase;ChemistrySelect;2020-05-15

3. Acetamide Derivatives of Chromen-2-ones as Potent Cholinesterase Inhibitors;Archiv der Pharmazie;2017-07-12

4. Amino derivatives of platanic acid act as selective and potent inhibitors of butyrylcholinesterase;European Journal of Medicinal Chemistry;2017-01

5. Enzyme Inhibitors Involved in the Treatment of Alzheimer’s Disease;Drug Design and Discovery in Alzheimer's Disease;2014